DA32 Life Science Tech Acquisition Corp. announced that it has entered into an agreement for private placement of 650,000 class A common stock at a price of $10 per common stock for gross proceeds of $650,000 on May 28, 2021. The transaction will include participation from returning investor DA32 Sponsor LLC. The company granted over-allotment option to the underwriters. The company will issue 710,000 class A common stock for gross proceeds of $7,100,000 in the transaction if the over-allotment option is exercised in full. The securities issued in the transaction are not transferable or salable until 30 days after the completion of our initial business combination.